Kumar Neil 13D/13G Filings for BridgeBio Pharma, Inc. (BBIO)

Kumar Neil 13D and 13G filings for BridgeBio Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-13
5:23 pm
Purchase		 2024-12-31 13G BridgeBio Pharma, Inc.
BBIO		 Kumar Neil 10,466,712
5.410%		 507,208increase
(+5.09%)		 Filing
2024-02-16
7:15 pm
Purchase		 2023-12-31 13G BridgeBio Pharma, Inc.
BBIO		 Kumar Neil 9,959,504
5.590%		 135,596increase
(+1.38%)		 Filing
2023-02-14
4:18 pm
Purchase		 2022-12-31 13G BridgeBio Pharma, Inc.
BBIO		 Kumar Neil 9,823,908
6.420%		 820,697increase
(+9.12%)		 Filing
2022-02-14
4:50 pm
Purchase		 2021-12-31 13G BridgeBio Pharma, Inc.
BBIO		 Kumar Neil 9,003,211
6.050%		 672,614increase
(+8.07%)		 Filing
2021-02-16
5:02 pm
Sale		 2020-12-31 13G BridgeBio Pharma, Inc.
BBIO		 Kumar Neil 8,330,597
6.740%		 -288,186decrease
(-3.34%)		 Filing